Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 417.5 GBX 1.21% Market Closed
Market Cap: 442.2m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Wall Street
Price Targets

OXB Price Targets Summary
Oxford BioMedica PLC

Wall Street analysts forecast OXB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OXB is 522.75 GBX with a low forecast of 383.8 GBX and a high forecast of 777 GBX.

Lowest
Price Target
383.8 GBX
8% Downside
Average
Price Target
522.75 GBX
25% Upside
Highest
Price Target
777 GBX
86% Upside
Oxford BioMedica PLC Competitors:
Price Targets
ARX
Aroa Biosurgery Ltd
45% Upside
BLAU3
Blau Farmaceutica SA
23% Upside
OCX
OncoCyte Corp
55% Upside
NVAX
Novavax Inc
106% Upside
PSTX
Poseida Therapeutics Inc
427% Upside
SRZN
Surrozen Inc
276% Upside
LGND
Ligand Pharmaceuticals Inc
8% Upside
DVAX
Dynavax Technologies Corp
95% Upside

Revenue
Forecast

Revenue Estimate
Oxford BioMedica PLC

For the last 8 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 24%. The projected CAGR for the next 3 years is 34%.

24%
Past Growth
34%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Oxford BioMedica PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Oxford BioMedica PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OXB's stock price target?
Price Target
522.75 GBX

According to Wall Street analysts, the average 1-year price target for OXB is 522.75 GBX with a low forecast of 383.8 GBX and a high forecast of 777 GBX.

What is Oxford BioMedica PLC's Revenue forecast?
Projected CAGR
34%

For the last 8 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 24%. The projected CAGR for the next 3 years is 34%.

Back to Top